EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The role of hemoglobin F in sickle cell disease complications: a descriptive secondary analysis

Heath Aston, Elexis Price, Elena Wernecke, Emma Hazenberg, Daniel Herrera, Siera Gollan, Hongyan Xu, Girindra Raval, Abdullah Kutlar

Blood Vessels, Thrombosis & Hemostasis · 2026-02 · 3 (1) · 100114

DOI: 10.1016/j.bvth.2025.100114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2026-02. Verfasst von Heath Aston und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Georgia, Augusta, GA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Individuals with sickle cell disease (SCD), a prevalent inherited blood disorder, are at increased risk for tissue ischemia and thrombosis secondary to sickle hemoglobin polymerization. Fetal hemoglobin (HbF) protects against the vaso-occlusive nature of sickled erythrocytes. Our study aims to investigate the association between HbF level and various SCD complications. The study used a descriptive and cross-sectional design to analyze existing, secondary medical record data of 496 patients with SCD who received care from the Center for Blood Disorders in Augusta, Georgia. Of these, only patients with HbSS and an HbSβ0 thalassemia (n = 273) were included in the analysis. Data abstraction included history of thrombotic event (TE) and HbF values closest to the TE, along with presence of SCD clinical complications, use of anticoagulation medications, specific laboratory values, and Hb electrophoresis. These patients were reflective of the greater population of patients with SCD in that they had similar rates of complications such as avascular necrosis and sickle cell retinopathy compared with nationally reported data. We found a significant association between incidence of thrombosis and higher HbF levels (P = .034). The presence of HbF was also found to influence the incidence of complications, including avascular necrosis and pulmonary hypertension. When stratified into quantiles, there was a relationship between HbF and incidence of AVN in male patients (P = .038). Further research is warranted to investigate whether other treatments for SCD produce similar results and whether this effect is representative of other large patient populations with SCD.

Autor:innen und Institutionen

  • Medical College of Georgia, Augusta, GA.
  • Center for Blood Disorders, Augusta, GA.
  • Department of Population Health Science, Augusta University, Augusta, GA.
  • Department of Medicine, Medical College of Georgia, Augusta, GA.

Zitieren

APA

Aston, H., Price, E., Wernecke, E., Hazenberg, E., Herrera, D., Gollan, S., Xu, H., Raval, G., & Kutlar, A. (2026). The role of hemoglobin F in sickle cell disease complications: a descriptive secondary analysis. Blood Vessels, Thrombosis & Hemostasis, 3(1), 100114. https://doi.org/10.1016/j.bvth.2025.100114

Vancouver

Aston H, Price E, Wernecke E, Hazenberg E, Herrera D, Gollan S, et al. The role of hemoglobin F in sickle cell disease complications: a descriptive secondary analysis. Blood Vessels, Thrombosis & Hemostasis. 2026;3(1):100114. doi:10.1016/j.bvth.2025.100114

BibTeX
@article{Aston2026,
  author = {Aston, Heath and Price, Elexis and Wernecke, Elena and Hazenberg, Emma and Herrera, Daniel and Gollan, Siera and Xu, Hongyan and Raval, Girindra and Kutlar, Abdullah},
  title = {The role of hemoglobin F in sickle cell disease complications: a descriptive secondary analysis},
  journal = {Blood Vessels, Thrombosis & Hemostasis},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {100114},
  doi = {10.1016/j.bvth.2025.100114}
}
Kostenlos starten →